Emerging within the UK, retatrutide, a novel molecule, is sparking considerable buzz within the healthcare community regarding its promise for body control . This dual GIP and GLP-1 agent agonist seems to deliver a significant benefit over current therapies, showing encouraging results in early clinical trials . Researchers believe its unique mecha